References
  Management of Thyroid Carcinoma

Ulla Feldt-Rasmussen


  1. Clark OH, Duh Q-Y. Thyroid cancer. In The thyroid gland. ed: Monte A. Greer, Raven Press, New York; 1990: pp 537-572.


  2. Kaplan MM (Ed). Thyroid carcinoma. Endocrinol and Metab Clin of North America.1990; 19: 469-766.


  3. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age and multinodularity. Am J Med 1992; 93: 363-369.


  4. Wynford-Thomas D. Molecular basis of epithelial tumorigenesis: the thyroid model. Crit Rev Oncogenesis 1993; 4: 1-23.


  5. Farid NR, Shi Y, Zou M. Molecular basis of thyroid cancer. Endocrine Rev 1994; 15: 202-232.


  6. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460.


  7. Lips CJM, Landsvater RM, Hoppener JWM, Geerdink RA, Blijham G, Jansen-Schillhorn van Veen JM, van Gils APG, de Wit MJ, Zewald RA, Berends MJH, Beemer FA, Brouwers-Smalbraak J, Jansen RPM, van Amstel HKP, van Vroonhoven TJMV, Vroom TM. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 1994; 331: 828-835.


  8. Williams ED, Pinchera A, Karaoglou A, Chadwick KH. Thyroid cancer in children living near Chernobyl. Expert panel report on the consequences of the Chernobyl accident. Commission of the European Communities. Report EUR 15248 1993; pp 1-108.


  9. Yoshimoto Y, Ezaki H, Etoh R, Hiraoka T, Akiba S. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985. Radiation Research 1995; 141: 278-286.


  10. Mazzaferi EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97: 418-428.


  11. Spencer CA, Nicoloff JT. Serum TSH measurement: A 1990 status report. Thyroid today 1990; XIII: 1-12.


  12. Burmeister LA. Thyroid hormone in the treatment of thyroid cancer. Thyroid today 1994; XVII: 1-9.


  13. Hoelting T, Tezelman S, Siperstein AE, Duh Q-Y, Clark. Biphasic effect of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro. Thyreoid 1995; 5: 35-40.


  14. Mazzaferi EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 1977; 56: 171-196.


  15. Mazzaferi EL. Impact of initial tumor features and treatment selected on the long-term course of differentiated thyroid cancer. Thyroid today 1995; XVIII: 1-13.


  16. Zlock DW, Greenspan FS, Clark OH, Higgins CB. Octreotide therapy in advanced thyroid cancer. Thyroid 1994; 4: 427-431.


  17. Feldt-Rasmussen U, Krogh Rasmussen A. Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo. J Endocrinol Invest 1985; 8: 571-579.


  18. Mariotti S, Barbesino G, Caturegli P, Marin6 M, Manetti L,Pacini F, Centoni R, Pinchera A. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: An unobtainable goal? J Clin Endocrinol Metab 1995; 80: 468-472.


  19. Spencer CA, Wang C-C. Thyroglobulin measurement: - Techniques, clinical benefits and pitfalls. Clinics of North America 1995; In Press.


  20. Schaadt B, Feldt-Rasmussen U, Rasmusson B, T0rring H, Foder B, J0rgensen K, Hansen HS. Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumour marker in differentiated thyroid carcinoma. Thyroid 1995; 5: 165-170.


  21. Kumar A, Shah DH, Shrihari U, Dandekar SR, Vijayan U, Sharma SM. Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid 1994; 4: 199-202.


  22. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, Pinchera A. Thyroid autoantibodies in thyroid cancer: Incidence and relationship with tumour outcome. Acta Endocrinol 1988; 119: 373-380.


  23. Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C, Pinchera A. Therapeutic doses of iodine131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987; 28: 1888-1891.


  24. Hufner M, Kiehne B, Stempka L, Bethauser H, Schulz R. Description of a variably expressed and labile epitope of thyroglobulin and its occurrence in different thyroid diseases using a monoclonal antibody. Clin Physiol Biochem 1992; 9: 35 40.